METHODS
To achieve the aim of the study, we designed a tandem to be made of polyamide 12 for the straight part
(4 and 6 centimeters on both sides) and Nitinol for the angled part (4 centimeters). Afterward, we placed
the produced tandem into the bolus and measured the dose using different dosimetry methods such
as the treatment planning system (TPS), GafChromic film dosimetry, and MOSFET dosimetry. Three
different measurements were made with the same irradiation dose for each measurement method, and
the average results were recorded.
RESULTS
The Euclidean distance between the source and the measuring point was 34.0 millimeters for the
Polyamide 12 part, and 32.8 millimeters for the Nitinol part. The calculated irradiation time was 284.9
seconds for the Polyamide 12 part and 268.2 seconds for the Nitinol part. Considering the irradiation
times and source distances, the calculated difference between Nitinol and Polyamide 12 was 1.15%. This
difference was 1.0%, 1.87%, and 2.08% for TG43, MOSFET, and GafChromic film dosimetry, respectively.
CONCLUSION
In conclusion, Nitinol did not have a negative effect on the dose distribution. However, these results
should be supported by further studies including other dosimetry measurements.
Keywords: Brachytherapy; gafchromic film dosimetry; MOSFET dosimetry; nitinol
The most studied SMP types are thermally induced
forms. Melting and glass transition temperatures are
the main two thermal transition factors underlying the
mechanism. As a result of direct thermal application
higher than the polymer's transition temperature, the
transitory shape of SMP can be programmed. Glass transition
temperature-based polymers have a slow shape recovery
feature compared to melting temperature-based
samples. In addition to this feature, temperatures of glass
transitions near physiological body temperature are appropriate
properties for biomedical applications.[
Nitinol is an alloy that contains Nickel (Ni), the
seventh most abundant transition metal with facecentered
cubic (FCC) coordination, and the twentysecond
most abundant element in the earth's crust,
Titanium (Ti), a transition metal. Nitinol deforms at
low temperatures and returns to its predetermined
shape when heated above its transformation temperature.
The most important feature of superelastic 55Ni-
45Ti tubes is that they can be bent ten times more than
steel tubes without kinking or collapsing. Because superelastic
Nitinol tubes can be bent ten times more
than steel tubes without kinking or collapsing, and
combined with wide biocompatibility, Nitinol is used
for manufacturing microsurgical equipment. Several
manufacturing methods of Nitinol have been developed,
such as melting, fabrication, forming, machining,
joining, finishing, coating, powder processes, and
thin film. Developments in laser cutting, forming, photochemical
etching, or surface finishing technologies
have improved the physical and mechanical properties
of Nitinol. The control of surface finish and corrosion
resistance plays a key role in medical implants.[
In this study, we aimed to make the dosimetric evaluation
of Nitinol to test its usability in Brachytherapy
treatment.
Dose Measurement
Three different dosimetry methods were used during
the dose measurements of the prototype produced
(treatment planning system (TPS) for virtual, Radiochromic
Film Dosimeter System (EBT3 model, Ashland
Specialty Ingredients, Bridgewater, NJ, USA), and
Mosfet Dosimeter (Best Medical Canada) system for
actual). To use these dosimetric methods, the calibration
of the Radiochromic Film Dosimeter System and
Mosfet Dosimeter systems was first performed. The distance
of the measuring points was chosen completely
randomly from TPS, and the Euclidean distance of the
measuring point for the Polyamide 12 and Nitinol sections
of the tandem was 34.0 and 32.8 mm, respectively.
Radiation Delivery
Planning was made using ACUROS BV and TG43-
based calculation algorithms to obtain a dose of 3.0 Gy
by selecting a single source position at the measurement
points determined virtually in the Treatment Planning
System, and the dose values obtained from both algorithms
were recorded. At the times calculated with the
ACUROS BV calculation algorithm, firstly, the MOSFET
detector (Fig.
Statistical Analysis
Categorical variables were described as counts and
percentages (%), whereas continuous variables were
described as means (±standard deviation). The correlations
(r values) were assessed using Pearson's
correlation coefficient. All tests of significance were
two-tailed with a p-value <0.01.
Although the standard of treatment in patients with
endometrial cancer is upfront surgery, several newly diagnosed
patients are unable to undergo surgery because
of medical comorbidities. In this situation, radiation
therapy can be used in patients with early-stage disease
for definitive management, in patients with locally advanced
disease for preoperative treatment, or for the
palliation of symptoms. Historically, low-dose-rate (LDR) or high-dose-rate (HDR) techniques have been
used in combination with EBRT and/or alone in appropriately
selected patients. Advances in imaging and radiation
therapy technology in recent years have allowed
for a more precise definition of tumor targets and the
potential for increased accuracy of dose delivery.[
The number of applicators that can be used in the
brachytherapy treatment of patients with endometrial
cancer who cannot undergo surgery is limited.
[
To evaluate the compatibility of the dose calculated
in the Treatment Planning System with the doses obtained
using different measurement methods, first of
all, the factors affecting the dose, which are time (directly
proportional), distance (inversely proportional
to the square), and activity (directly proportional) values,
should be known. The activity during irradiation
directly affects the duration, and the Treatment Planning
System updates the calculated duration by taking
into account the activity of the source (vertical factor).
Therefore, the activity was ignored in the evaluation.
Since measurements will be made at different thicknesses due to the structure of the applicator, the irradiation
dose was kept constant, and the uncertainty of
one more value in the formulation was eliminated.
When the literature is examined, the percentage of
total uncertainty was calculated as 8.4% in low-dose
regions (≤100 cGy) and 6.9% in high-dose regions (>100 cGy) in measurements made with EBT3 film
and 192Ir radioactive-derived brachytherapy systems.
[
Authorship contributions: Concept - A.Ö.; Design - A.Ö., K.D.; Supervision - A.Ö.; Funding - A.Ö.; Materials - A.Ö., K.D., H.İ.; Data collection and/or processing - K.D., H.İ.; Data analysis and/or interpretation - A.Ö., K.D.; Literature search - A.Ö., K.D.; Writing - A.Ö., K.D.; Critical review - A.Ö.
Conflict of Interest: All authors declared no conflict of interest. Use of AI for Writing Assistance: Not declared.
Financial Support: This study has been supported by The Scientific and Technological Research Council of Türkiye as project number: 220S572.
Peer-review: Externally peer-reviewed.